#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15674	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2017	765.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1439	1439	C	918	C	882	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15674	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2017	765.5	0	HET	.	.	.	C451T	.	451	451	C	706	706	C	925	C,T	675,207	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15674	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2017	765.5	0	HET	.	.	.	C207T	.	207	207	C	462	462	C	814	C,T	618,144	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29060	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3453	834.1	0	.	n	.	0	T695C	SNP	695	695	T	974	974	C	907	C	873	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29060	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3453	834.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2250	2250	C	890	C	848	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29060	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3453	834.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2324	2324	A	876	A	850	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29060	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3453	834.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2876	2876	C	891	C	860	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29060	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3453	834.1	0	HET	.	.	.	A1638G	.	1638	1638	A	1917	1917	A	938	A,G	720,188	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1868	folP	855	855	100.0	folP.l15.c4.ctg.1	1509	122.6	1	SNP	p	R229S	1	.	.	685	687	AGC	955	957	AGC	189;189;191	A;G;C	181;182;183	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4828	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	140.6	1	SNP	p	S91F	1	.	.	271	273	TTC	545	547	TTC	167;167;170	T;T;C	160;162;164	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4828	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	140.6	1	SNP	p	G95N	0	.	.	283	285	GGC	557	559	GGC	170;169;168	G,T;G,C;C	162,1;163,1;160	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4828	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3412	140.6	1	SNP	p	D95G	1	.	.	283	285	GGC	557	559	GGC	170;169;168	G,T;G,C;C	162,1;163,1;160	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1546	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1383	111.1	1	SNP	p	G45D	0	.	.	133	135	GGC	456	458	GGC	174;175;176	G;G;C	170;171;172	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	944	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1006	92.5	0	.	n	.	0	A197.	DEL	197	197	A	556	556	A	226	A	223	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4596	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3038	149.8	1	SNP	p	D86N	0	.	.	256	258	GAC	702	704	GAC	206;208;207	G;A;C	201;197;206	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4596	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3038	149.8	1	SNP	p	R87I	0	.	.	259	261	CGT	705	707	CGT	207;206;203	C,A;G;T	202,1;202;197	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4596	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3038	149.8	1	SNP	p	R87W	0	.	.	259	261	CGT	705	707	CGT	207;206;203	C,A;G;T	202,1;202;197	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4596	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3038	149.8	1	SNP	p	S87R	1	.	.	259	261	CGT	705	707	CGT	207;206;203	C,A;G;T	202,1;202;197	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4596	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3038	149.8	1	SNP	p	S88P	0	.	.	262	264	TCC	708	710	TCC	203;202;204	T;C;C	199;199;199	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3828	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2761	137.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1566	1568	GGC	200;198;196	G;G;C,T,A	193;192;184,1,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4252	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2312	181.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1155	1157	GCC	218;219;219	G;C,T;C	207;209,1;209	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4252	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2312	181.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1158	1160	ATG	216;216;218	A;T;G	205;202;208	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4252	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2312	181.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1170	1172	ACC	231;229;231	A;C;C	221;222;220	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4252	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2312	181.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1170	1172	ACC	231;229;231	A;C;C	221;222;220	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4252	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2312	181.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1671	1673	ACC	196;199;199	A;C;C	183;193;193	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4252	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2312	181.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1725	1727	GCG	212;213;211	G;C;G	198;203;203	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4252	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2312	181.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1725	1727	GCG	212;213;211	G;C;G	198;203;203	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4252	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2312	181.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1848	1850	GGT	160;159;157	G;G;T	155;153;149	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4252	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2312	181.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1857	1859	AGC	153;151;150	A;G;C	145;144;145	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4252	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2312	181.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1875	1877	CCG	120;122;125	C,G;C,G;G	103,7;103,4;100	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5630	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3089	180.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1659	1661	CCG	190;188;188	C;C,A;G,A	180;182,1;178,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1936	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1673	114.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	522	522	C	126	C	118	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3112	porB1b	1038	1038	98.86	porB1b.l6.c4.ctg.1	1699	181.5	0	.	p	.	0	N134_V135insNLPA	INS	400	400	A	756	756	A	237	A	233	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3112	porB1b	1038	1038	98.86	porB1b.l6.c4.ctg.1	1699	181.5	1	SNP	p	G120K	1	.	.	358	360	AAG	713	715	AAG	238;241;240	A,C;A;G	230,2;235;228	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3112	porB1b	1038	1038	98.86	porB1b.l6.c4.ctg.1	1699	181.5	1	SNP	p	A121N	1	.	.	361	363	AAC	716	718	AAC	238;239;238	A;A;C,A	228;235;225,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3112	porB1b	1038	1038	98.86	porB1b.l6.c4.ctg.1	1699	181.5	1	SNP	p	N121D	0	.	.	361	363	AAC	716	718	AAC	238;239;238	A;A;C,A	228;235;225,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11370	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4733	238.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1232	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	928	130.2	1	SNP	p	V57M	1	.	.	169	171	ATG	415	417	ATG	242;244;243	A;T;G	236;235;237	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
